Global Shoulder Replacement Devices Market -2024-2031

Global Shoulder Replacement Devices Market -2024-2031


Global shoulder replacement devices market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031.

Shoulder replacement devices are used for shoulder replacement procedure that tries to eliminate the source of pain and dysfunction by replacing damaged parts of the shoulder joint with prostheses. The most common reasons for a shoulder replacement surgery are osteoarthritis, rotator cuff tear arthropathy, avascular necrosis or rheumatoid arthritis. The procedure is meant to relieve the pain, improve strength, increase the range of motion and enable to use shoulder and arm.

Shoulder devices are available in a few different shapes and range of sizes. Replacement options include partial and total using either anatomic or reverse devices. During shoulder replacement surgery, the damaged or diseased parts of the joint are removed and replaced with artificial devices made of materials such as metal alloys, ceramics or polyethylene.

Market Dynamics: Drivers

Rising advancements in shoulder replacement devices

The rising advancements in shoulder replacement devices are expected to drive the market over the forecast period. The integration of computer-assisted navigation systems, AI-based shoulder replacement devices and robotic technology into shoulder replacement surgery allows for greater precision, accuracy and reproducibility in device placement. These technologies enable surgeons to achieve optimal alignment, device positioning and soft tissue balancing, ultimately leading to improved functional outcomes and patient satisfaction.

For instance, on February 22, 2024, Zimmer Biomet Holdings, Inc. cleared the U.S. Food and Drug Administration (FDA) 510(k) clearance of the ROSA Shoulder System for robotic-assisted shoulder replacement surgery. ROSA Shoulder is the world's first robotic surgery system for shoulder replacement and the fourth application for the Company's comprehensive ROSA Robotics portfolio.

In addition, on January 30, 2020, RSIP Vision, a developer of artificial intelligence (AI) and computer vision technology, created a new AI-based shoulder replacement solution that will be integrated into vendors' surgical planning platforms. The product is designed to improve physicians' workflow, giving them a precise 3D anatomical model of the patient shoulder, which will enable better navigation through various tissues found in the proximity of the problematic area and better planning of the complex surgery, while saving time and dramatically increasing the surgical outcome.

Manufacturers are continually innovating and refining the design of shoulder replacement devices to better mimic the natural anatomy of the shoulder joint. Anatomically shaped devices, modular systems and customizable options are becoming more prevalent, allowing surgeons to tailor the treatment to each patient's unique anatomy and pathology.

For instance, on April 13, 2022, Medacta launched its unique NextAR Shoulder, the first CE-marked and FDA-cleared augmented reality surgical application with intraoperative guidance for total shoulder replacement, following the responsible introduction under the M.O.R.E. Excellence Clinical Program's plan of action. NextAR Shoulder leverages synergy with the complete and convertible Medacta Shoulder System to provide surgeons with the possibility of tailoring the implant choice to the patient's needs. Moreover, this innovative technology is part of Medacta’s MySolutions Personalized Ecosystem, an advanced network of digital solutions designed to improve patient outcomes and healthcare efficiency.

Further, the increasing prevalence of shoulder-related disorders, rising FDA approvals for various novel devices, increasing clinical trials to develop more advanced devices, increasing awareness about the available shoulder replacement devices and rising technological advancements are the factors expected to drive the market over the forecast period.

Restraints

Factors such as the high cost associated with these devices and associated surgery, risks and complications associated with the surgery, availability of alternative devices and regulatory challenges are the factors expected to hamper the market over the forecast period.

For more details on this report - Request for Sample

Segment Analysis

The global shoulder replacement devices market is segmented based on product type, end-user and region.

The reverse shoulder replacement devices segment accounted for approximately 35.5% of the shoulder replacement devices market share

The reverse shoulder replacement devices segment is expected to hold the largest market share over the forecast period. Reverse shoulder replacement surgery employs a prosthesis to switch the anatomy of the normal shoulder, placing the cup at the humerus and the ball at the shoulder socket and shifting the burden of movement in the joint from the rotator cuff muscles to the deltoid muscles. This simple arrangement avoids the displacement, instability and limitation of motion associated with conventional arthroplasty in the indicated patient populations.

For instance, on September 19, 2023, Anika Therapeutics launched its RevoMotion Reverse Shoulder Arthroplasty System (RSA). RevoMotion expands the company’s shoulder arthroplasty portfolio and provides a bone-conserving and innovative solution in the $1 billion U.S. reverse shoulder market. RevoMotion Reverse Shoulder Arthroplasty System is designed specifically to address clinical needs through a truly bone-preserving design with simple and efficient instrumentation.

Manufacturers have made significant advancements in the design and development of reverse shoulder replacement implants, leading to more reliable and durable devices. Modern implants offer improved fixation, reduced wear rates and optimized biomechanics, resulting in better long-term outcomes for patients undergoing reverse shoulder replacement surgery.

For instance, on August 23, 2021, Shoulder Innovations Inc, a leading innovator in the development of shoulder replacement systems, cleared the FDA clearance for their InSet Reverse Shoulder Arthroplasty System. The InSet technology has been shown in testing to significantly reduce glenoid implant micro-motion and simplify the surgical technique, potentially reducing complications or increasing implant longevity.

Geographical Analysis

North America accounted for approximately 42.1% of the market share

North America region is expected to hold the largest market share over the forecast period owing to the strong presence of major players and rising demand for shoulder replacement devices. North America especially the United States is a very well-known hub for its strong presence of major players such as medical device companies. This presence of major players in the region focuses on developing more advanced devices with minimal complications.

For instance, on August 18, 2021, DePuy Synthes, the Orthopaedics Company of Johnson & Johnson, introduced the INHANCE Shoulder System, a first-to-market, fully integrated shoulder arthroplasty system. The system is designed with an intuitive stemless-first surgical approach that aligns with how surgeons approach patient care. The INHANCE Shoulder System is the first shoulder system to offer surgeons the ability to seamlessly transition from stemless to stemmed implants during surgical procedures.

In addition, there is a rising demand for shoulder replacement devices in the region especially in the United States due to the increasing number of shoulder replacement procedures in the region. For instance, on February 13, 2024, Smith+Nephew cleared the commercial availability of its AETOS Shoulder System in the US, along with 510(k) clearance for its use with ATLASPLAN 3D Planning Software and Patient Specific Instrumentation for total shoulder arthroplasty. Total shoulder arthroplasty is one of the fastest-growing segments in Orthopaedics with an estimated 250,000 procedures in the US by 2025.

Competitive Landscape

The major global players in the shoulder replacement devices market include Zimmer Biomet Holdings, Inc, DePuy Synthes, DJO, LLC, Arthrex, Inc., Smith+Nephew, Stryker Corporation, Wright Medical Group N.V., Anika Therapeutics, Inc., Exactech, Inc. and Medacta International among others.

COVID-19 Impact Analysis

The COVID-19 pandemic significantly impacted the global shoulder replacement devices market. During the height of the pandemic, many healthcare systems faced overwhelming pressures and elective surgeries, including shoulder replacement procedures, were often postponed or canceled to conserve resources, minimize the risk of virus transmission and prioritize care for COVID-19 patients. This led to a significant reduction in procedure volumes and revenue loss for healthcare providers and manufacturers of shoulder replacement devices.

For instance, according to the National Institute of Health, a total of 49,412 and 41,554 total shoulder arthroplasty (TSA) cases were observed from April through December 2019 and 2020, respectively. There was an overall decrease in shoulder arthroplasty volume per 1000 Medicare beneficiaries by 14% during the COVID-19 pandemic.

Market Segmentation

By Product Type
● Total Shoulder Replacement Devices
● Reverse Shoulder Replacement Devices
● Resurfacing Hemiarthroplasty Devices
● Stemmed Hemiarthroplasty Devices

By End-User
● Hospitals
● Specialty Clinics
● Ambulatory Surgical Centers
● Academic and Research Institutes
● Others

By Region
● North America
U.S.
Canada
Mexico
● Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
● South America
Brazil
Argentina
Rest of South America
● Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
● Middle East and Africa

Why Purchase the Report?
● To visualize the global shoulder replacement devices market segmentation based on product type, end-user and region as well as understand key commercial assets and players.
● Identify commercial opportunities by analyzing trends and co-development
● Excel data sheet with numerous data points of shoulder replacement devices market-level with all segments.
● PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
● Product mapping available as excel consisting of key products of all the major players.

The global shoulder replacement devices market report would provide approximately 53 tables, 50 figures and 187 Pages.

Target Audience 2024
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies


1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by End-User
3.3. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Advancements in Shoulder Replacement Devices
4.1.2. Restraints
4.1.2.1. High Cost Associated with the Devices
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. PESTEL Analysis
5.7. Patent Analysis
5.8. SWOT Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Total Shoulder Replacement Devices *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Reverse Shoulder Replacement Devices
7.4. Resurfacing Hemiarthroplasty Devices
7.5. Stemmed Hemiarthroplasty Devices
8. By End-User
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Specialty Clinics
8.4. Ambulatory Surgical Centers
8.5. Academic and Research Institutes
8.6. Others
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.5.1. U.S.
9.2.5.2. Canada
9.2.5.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.5.1. Germany
9.3.5.2. UK
9.3.5.3. France
9.3.5.4. Italy
9.3.5.5. Spain
9.3.5.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.5.1. Brazil
9.4.5.2. Argentina
9.4.5.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.5.1. China
9.5.5.2. India
9.5.5.3. Japan
9.5.5.4. Australia
9.5.5.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. Zimmer Biomet Holdings, Inc*
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Financial Overview
11.1.4. Key Developments
11.2. DePuy Synthes
11.3. DJO, LLC
11.4. Arthrex, Inc.
11.5. Smith+Nephew
11.6. Stryker Corporation
11.7. Wright Medical Group N.V.
11.8. Anika Therapeutics, Inc.
11.9. Exactech, Inc.
11.10. Medacta International
LIST NOT EXHAUSTIVE
12. Appendix
12.1. About Us and Services
12.2. Contact Us

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings